Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CEO Of China's Leading Vaccine Producer Reveals Latest Vaccine Scandal Has Triggered A Sector-wide Boycott, Throwing Firm Into The Red

This article was originally published in PharmAsia News

Executive Summary

BEIJING - The chief executive officer of Sinovac Biotech, China's leading vaccine developer, told investors this week that the country's latest vaccine scandal had poisoned public perceptions so deeply that many citizens are boycotting the entire sector

You may also be interested in...



China's Leading Vaccine Developer Sees Sales Slashed Due To Popular Backlash Against Series Of Scandals

BEIJING - Pummeled by a de facto nationwide public boycott of domestically produced inoculations following a series of faulty vaccine releases by other firms that have in some cases led to fatalities, China's leading vaccine maker, Sinovac Biotech, reported sales revenues for 2010 that were just half of original projections

China's Leading Vaccine Developer Sees Sales Slashed Due To Popular Backlash Against Series Of Scandals

BEIJING - Pummeled by a de facto nationwide public boycott of domestically produced inoculations following a series of faulty vaccine releases by other firms that have in some cases led to fatalities, China's leading vaccine maker, Sinovac Biotech, reported sales revenues for 2010 that were just half of original projections

China's Sinovac Sees Profits Plummet In Wake Of Public Fears Following Vaccine Scandals By Other Producers

BEIJING - China's leading vaccine developer, Sinovac Biotech, posted a steep fall in profits for the second quarter, and revealed that the World Health Organization is working with Chinese regulators on monitoring good manufacturing practice standards following a series of scandals that have hurt the entire sector

Related Content

Latest News
UsernamePublicRestriction

Register

SC074809

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel